Nurse Practitioner, Adult Health · Ridgeland, MS
NPI
1083040562
Since 2013
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
625 S Pear Orchard Rd, Ste B
Ridgeland, MS, 39157
Phone (601) 499-0282
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
1,336 services
Medicare patients, 2024
159
Average age 67
Drug cost, 2024
$8.4M
3,749 prescriptions
Company payments, 2025
$16K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amanda B Greene was code 99215 (office e&m - established), 212 times for 103 patients. In total Amanda B Greene billed 1,336 services in 15 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 212 | 103 | $97.04 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 179 | 116 | $8.70 | $1,558 |
| 99214 Office E&M - Established | Office | 92 | 55 | $63.67 | $5,857 |
| 99205 Office E&M - New | Office | 41 | 41 | $122.60 | $5,027 |
| 99213 Office E&M - Established | Office | 23 | 16 | $36.49 | $839 |
| 99204 Office E&M - New | Office | 21 | 21 | $66.90 | $1,405 |
By year: 2022 $21K for 492 services; 2023 $69K for 2,818 services; 2024 $41K for 1,336 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 35 | 30 | $4.66 | $163 |
Medicare prescription drug claims, 2024
In 2024, the drug Amanda B Greene prescribed most often to Medicare patients was Baclofen, with 311 prescriptions and refills. In total Amanda B Greene wrote 3,749 Medicare prescriptions that cost $8.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 311 | 441 | 67 | $4,713 |
| Gabapentin Generic | 262 | 321 | 46 | $3,321 |
| Dalfampridine Er Dalfampridine | 183 | 209 | 24 | $75K |
| Tysabri Natalizumab | 168 | 179 | 21 | $1.4M |
| Sodium Chloride 0.9 % Sodium Chloride | 148 | 153 | 33 | $566 |
| Amitriptyline Hcl Generic | 104 | 158 | 21 | $676 |
| Acyclovir Generic | 84 | 110 | 14 | $472 |
| Tizanidine Hcl Generic | 83 | 133 | 17 | $845 |
| Methylprednisolone Sodium Succ Methylprednisolone Sod Succ | 82 | 141 | 40 | $1,625 |
| Diphenhydramine Hcl Generic | 77 | 172 | 39 | $138 |
| Zolpidem Tartrate Generic | 69 | 71 | Under 11 | $397 |
| Topiramate Generic | 66 | 124 | 16 | $541 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 61 | 61 | Under 11 | $94K |
| Modafinil Generic | 60 | 64 | Under 11 | $2,794 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 59 | 125 | 15 | $494 |
Brand drugs: 874 claims; generic drugs: 2,875 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amanda B Greene $16K ($16K in general payments such as food, travel and fees) from 34 companies. The largest payer was TG Therapeutics, Inc. with $6,011.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 23 | $6,011 |
| Sanofi US Services Inc. SNY | 1 | $2,581 |
| Biogen, Inc. BIIB | 19 | $574 |
| EMD Serono, Inc. MRK.DE | 15 | $476 |
| Pfizer Inc. PFE | 25 | $474 |
| Mallinckrodt Hospital Products Inc. | 15 | $455 |
| SK Life Science, Inc. | 15 | $418 |
| Lundbeck LLC | 23 | $406 |
| Abbvie Inc. ABBV | 26 | $379 |
| Axsome Therapeutics, Inc. AXSM | 13 | $338 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.